@prefix rdf:	<http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dbpedia:	<http://dbpedia.org/resource/> .
@prefix dbpedia-owl:	<http://dbpedia.org/ontology/> .
dbpedia:Nitrazepam	rdf:type	dbpedia-owl:Drug .
@prefix owl:	<http://www.w3.org/2002/07/owl#> .
dbpedia:Nitrazepam	rdf:type	owl:Thing ;
	owl:sameAs	<http://rdf.freebase.com/ns/guid.9202a8c04000641f800000000043119d> .
@prefix foaf:	<http://xmlns.com/foaf/0.1/> .
@prefix ns5:	<http://en.wikipedia.org/wiki/> .
dbpedia:Nitrazepam	foaf:page	ns5:Nitrazepam .
@prefix ns6:	<http://dbpedia.org/ontology/Drug/> .
dbpedia:Nitrazepam	ns6:atcPrefix	"N05" ;
	ns6:atcSuffix	"CD02" ;
	ns6:casNumber	"146-22-5" ;
	dbpedia-owl:drugbank	"none" ;
	ns6:drugbank	"none" ;
	ns6:iupacName	"9-nitro- 6-phenyl- 2,5-diazabicyclo [5.4.0] undeca- 5,8,10,12- tetraen- 3-one" ;
	dbpedia-owl:pubchem	"4506" .
@prefix dbpprop:	<http://dbpedia.org/property/> .
dbpedia:Nitrazepam	dbpprop:reference	<http://www.pbs.gov.au/pi/afpalodo10705.pdf> ,
		<http://www.betterhealth.vic.gov.au/bhcv2/bhcmed.nsf/pages/afcalodo/$File/afcalodo.pdf> ,
		<http://www.inchem.org/documents/pims/pharm/pim675.htm> ,
		<http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20(General%20Monographs-%20M)/MOGADON.html> ,
		<http://www.thetrap.org.uk> .
@prefix rdfs:	<http://www.w3.org/2000/01/rdf-schema#> .
dbpedia:Nitrazepam	rdfs:label	"Nitrazepam"@tr ,
		"Nitrazepam"@pl ,
		"\u30CB\u30C8\u30E9\u30BC\u30D1\u30E0"@ja ,
		"Nitraz\u00E9pam"@fr ,
		"Nitrazep\u00E1m"@hu ,
		"Nitrazepam"@de ,
		"\u041D\u0438\u0442\u0440\u0430\u0437\u0435\u043F\u0430\u043C"@ru ,
		"Nitratsepaami"@fi ,
		"Nitrazepam"@en ,
		"Nitrazepam"@sv ;
	dbpedia-owl:thumbnail	<http://upload.wikimedia.org/wikipedia/commons/thumb/6/6e/Nitrazepam.svg/200px-Nitrazepam.svg.png> ;
	dbpedia-owl:atcPrefix	"N05" ;
	dbpedia-owl:atcSuffix	"CD02" ;
	dbpedia-owl:casNumber	"146-22-5" ;
	dbpedia-owl:iupacName	"9-nitro- 6-phenyl- 2,5-diazabicyclo [5.4.0] undeca- 5,8,10,12- tetraen- 3-one" ;
	ns6:pubchem	"4506" ;
	dbpprop:abstract	"\u30CB\u30C8\u30E9\u30BC\u30D1\u30E0\uFF08Nitrazepam, \u5546\u54C1\u540D Alodorm\u00AE, Mogadon\u00AE, Nitredon\u00AE, Nilandron\u00AE \u306A\u3069\uFF09\u306F\u3001\u30D9\u30F3\u30BE\u30B8\u30A2\u30BC\u30D4\u30F3\u7CFB\u4E2D\u9593\u578B\u306E\u7761\u7720\u5C0E\u5165\u5264\uFF08\u7761\u7720\u85AC\uFF09\u3067\u3042\u308B\u30021967\u5E74\u306B\u5869\u91CE\u7FA9\u88FD\u85AC\u304C\u5546\u54C1\u540D\u30D9\u30F3\u30B6\u30EA\u30F3 (Benzarin) \u3068\u3057\u3066\u958B\u767A\u30FB\u767A\u58F2\u3057\u305F\u3002 \u5264\u5F62\u306B\u306F 2, 5, 10 mg \u306E\u9320\u5264\u3068 1% 1g \u306E\u7D30\u7C92\u304C\u3042\u308B\u3002 \u5927\u8846\u85AC\uFF08OTC\u533B\u85AC\u54C1\uFF09\u306B\u6B66\u7530\u85AC\u54C1\u5DE5\u696D\u306E\u98A8\u90AA\u85AC\u300C\u30D9\u30F3\u30B6\u300D\u304C\u3042\u308B\u304C\u3001\u540D\u524D\u304C\u4F3C\u3066\u3044\u308B\u3060\u3051\u3067\u7121\u95A2\u4FC2\u3067\u3042\u308B\uFF08\u767A\u58F2\u306F\u5869\u91CE\u7FA9\u306E\u65B9\u304C\u65E9\u3044\uFF09\u3002"@ja ,
		"La Nitraz\u00E9pam est une substance chimique de la famille des benzodiaz\u00E9pines notamment commercialis\u00E9e sous le nom de Mogadon \u00AE, ainsi que sous forme de m\u00E9dicament g\u00E9n\u00E9rique. (D'autres sp\u00E9cialit\u00E9s en contenant existent, comme Imeson\u00AE). Comme toutes les mol\u00E9cules de sa famille, elle poss\u00E8de des propri\u00E9t\u00E9s anxiolytiques, hypnotiques ou s\u00E9datives, anticonvulsantes, et myorelaxantes, mais elle est surtout utilis\u00E9e comme hypnotique."@fr ,
		"\u041D\u0438\u0442\u0440\u0430\u0437\u0435\u043F\u0430\u043C\u00A0\u2014 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0435\u043D\u043D\u043E\u0435 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u043E. \u0421\u0432\u0435\u0442\u043B\u043E-\u0436\u0451\u043B\u0442\u044B\u0439 \u0438\u043B\u0438 \u0441\u0432\u0435\u0442\u043B\u043E-\u0436\u0451\u043B\u0442\u044B\u0439 \u0441 \u0437\u0435\u043B\u0435\u043D\u043E\u0432\u0430\u0442\u044B\u043C \u043E\u0442\u0442\u0435\u043D\u043A\u043E\u043C \u043A\u0440\u0438\u0441\u0442\u0430\u043B\u043B\u0438\u0447\u0435\u0441\u043A\u0438\u0439 \u043F\u043E\u0440\u043E\u0448\u043E\u043A, \u043F\u0440\u0430\u043A\u0442\u0438\u0447\u0435\u0441\u043A\u0438 \u043D\u0435\u0440\u0430\u0441\u0442\u0432\u043E\u0440\u0438\u043C \u0432 \u0432\u043E\u0434\u0435, \u043C\u0430\u043B\u043E\u0440\u0430\u0441\u0442\u0432\u043E\u0440\u0438\u043C \u0432 \u0441\u043F\u0438\u0440\u0442\u0435 \u0438 \u044D\u0444\u0438\u0440\u0435."@ru ,
		"Nitrazepam (en \u00E7ok rastlanan ticar\u00EE adlar\u0131yla Mogadon veya Alodorm), bir benzodiazepin (1,4-diazepin) t\u00FCrevi ila\u00E7 tipidir. Sedatif ve devinim bozma etkilerine de sahip olan bir hepatik ila\u00E7 etken maddesidir."@tr ,
		"Nitrazepam - lek nasenny i uspokajaj\u0105cy, pochodna benzodiazepiny. Skutkami ubocznymi dzia\u0142ania leku mog\u0105 by\u0107 m. in. brak koncentracji, problemy z pami\u0119ci\u0105, poczucie zm\u0119czenia. Nitrazepam dzia\u0142a na o\u015Brodki limbiczne i podwzg\u00F3rze. Zwi\u0119ksza powinowactwo kwasu gamma-aminomas\u0142owego do receptora GABA-A. Wykazuje przede wszystkim komponent\u0119 nasenn\u0105."@pl ,
		"A nitrazep\u00E1m egy benzodiazepin szerkezet\u0171 szorong\u00E1sold\u00F3, g\u00F6rcsold\u00F3, altat\u00F3, epilepszia-ellenes gy\u00F3gyszer."@hu ,
		"Nitrazepam is a type of benzodiazepine drug and is marketed in English-speaking countries under the following brand names - Alodorm, Arem, Insoma, Mogadon, Nitrados, Nitrazadon, Ormodon, Paxadorm, Remnos and Somnite. It is a hypnotic drug with sedative and motor impairing properties, anxiolytic, amnestic, anticonvulsant and skeletal muscle relaxant properties. Nitrazepam is available in 5mg and 10mg tablets. In Australia, Israel and the United Kingdom it is only available in 5mg tablets. The Dutch, British and French system called the System of Objectified Judgement Analysis for assessing whether drugs should be included in drug formularies based on clinical efficacy, adverse effects, pharmacokinetic properties, toxicity and drug interactions was used to assess nitrazepam. A Dutch analysis using the system found that nitrazepam is unsuitable to be included in drug prescribing formularies."@en ,
		"Nitrazepam, C15H11N3O3, \u00E4r ett \u00E5ngestd\u00E4mpande och lugnande preparat som tillh\u00F6r gruppen bensodiazepiner. Varunamn i Sverige f\u00F6r \u00E4mnet \u00E4r Apodorm, Mogadon och Nitrazepam Recip. Nitrazepam anv\u00E4nds som s\u00F6mnmedel vid olika former av s\u00F6mnst\u00F6rningar, som till exempel sv\u00E5righeter att somna in, f\u00F6r tidigt uppvaknande och f\u00F6r m\u00E5nga nattliga uppvaknande. Nitrazepam anv\u00E4nds \u00E4ven vid behandling av vissa former av epilepsi, som fr\u00E4mst drabbar barn (infantil spasm och petit mal). Vid epilepsi f\u00F6rhindrar \u00E4mnet att signaler, som utl\u00F6ser ett epileptiskt anfall, sprids i hj\u00E4rnan. Risk f\u00F6r tillv\u00E4njning f\u00F6religger, och l\u00E4kemedlen \u00E4r narkotikaklassade."@sv ,
		"Nitratsepaami on bentsodiatsepiinijohdos, jota k\u00E4ytet\u00E4\u00E4n p\u00E4\u00E4asiassa unettomuuden sek\u00E4 joidenkin epilepsiamuotojen hoitamiseen. Nitratsepaamiin, kuten muihinkin bentsodiatsepiineihin voi kehitty\u00E4 riippuvuus ja toleranssi. Siksi sen k\u00E4ytt\u00F6 on perusteltua vain l\u00E4\u00E4k\u00E4rin m\u00E4\u00E4r\u00E4yksest\u00E4 ja tarkoin ohjeita noudattaen. Nitratsepaamin kemiallinen kaava on C15H11N3O3, moolimassa 281,3 g/mol ja CAS-numero 146-22-5."@fi ,
		"Nitrazepam ist ein Arzneistoff aus der Gruppe der Benzodiazepine, mit ausgepr\u00E4gten hypnotischen und antikonvulsiven Eigenschaften und wird zur symptomatischen Behandlung von Schlafst\u00F6rungen und in der Behandlung der juvenilen Epilepsie eingesetzt. Es kann schon nach kurzer Anwendung zu einer psychischen und k\u00F6rperlichen Abh\u00E4ngigkeit kommen."@de ;
	rdfs:comment	"Nitrazepam (en \u00E7ok rastlanan ticar\u00EE adlar\u0131yla Mogadon veya Alodorm), bir benzodiazepin (1,4-diazepin) t\u00FCrevi ila\u00E7 tipidir. Sedatif ve devinim bozma etkilerine de sahip olan bir hepatik ila\u00E7 etken maddesidir."@tr ,
		"Nitratsepaami on bentsodiatsepiinijohdos, jota k\u00E4ytet\u00E4\u00E4n p\u00E4\u00E4asiassa unettomuuden sek\u00E4 joidenkin epilepsiamuotojen hoitamiseen. Nitratsepaamiin, kuten muihinkin bentsodiatsepiineihin voi kehitty\u00E4 riippuvuus ja toleranssi. Siksi sen k\u00E4ytt\u00F6 on perusteltua vain l\u00E4\u00E4k\u00E4rin m\u00E4\u00E4r\u00E4yksest\u00E4 ja tarkoin ohjeita noudattaen. Nitratsepaamin kemiallinen kaava on C15H11N3O3, moolimassa 281,3 g/mol ja CAS-numero 146-22-5."@fi ,
		"\u041D\u0438\u0442\u0440\u0430\u0437\u0435\u043F\u0430\u043C\u00A0\u2014 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432\u0435\u043D\u043D\u043E\u0435 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u043E. \u0421\u0432\u0435\u0442\u043B\u043E-\u0436\u0451\u043B\u0442\u044B\u0439 \u0438\u043B\u0438 \u0441\u0432\u0435\u0442\u043B\u043E-\u0436\u0451\u043B\u0442\u044B\u0439 \u0441 \u0437\u0435\u043B\u0435\u043D\u043E\u0432\u0430\u0442\u044B\u043C \u043E\u0442\u0442\u0435\u043D\u043A\u043E\u043C \u043A\u0440\u0438\u0441\u0442\u0430\u043B\u043B\u0438\u0447\u0435\u0441\u043A\u0438\u0439 \u043F\u043E\u0440\u043E\u0448\u043E\u043A, \u043F\u0440\u0430\u043A\u0442\u0438\u0447\u0435\u0441\u043A\u0438 \u043D\u0435\u0440\u0430\u0441\u0442\u0432\u043E\u0440\u0438\u043C \u0432 \u0432\u043E\u0434\u0435, \u043C\u0430\u043B\u043E\u0440\u0430\u0441\u0442\u0432\u043E\u0440\u0438\u043C \u0432 \u0441\u043F\u0438\u0440\u0442\u0435 \u0438 \u044D\u0444\u0438\u0440\u0435."@ru ,
		"A nitrazep\u00E1m egy benzodiazepin szerkezet\u0171 szorong\u00E1sold\u00F3, g\u00F6rcsold\u00F3, altat\u00F3, epilepszia-ellenes gy\u00F3gyszer."@hu ,
		""@ja ,
		"Nitrazepam ist ein Arzneistoff aus der Gruppe der Benzodiazepine, mit ausgepr\u00E4gten hypnotischen und antikonvulsiven Eigenschaften und wird zur symptomatischen Behandlung von Schlafst\u00F6rungen und in der Behandlung der juvenilen Epilepsie eingesetzt. Es kann schon nach kurzer Anwendung zu einer psychischen und k\u00F6rperlichen Abh\u00E4ngigkeit kommen."@de ,
		"Nitrazepam - lek nasenny i uspokajaj\u0105cy, pochodna benzodiazepiny. Skutkami ubocznymi dzia\u0142ania leku mog\u0105 by\u0107 m. in. brak koncentracji, problemy z pami\u0119ci\u0105, poczucie zm\u0119czenia. Nitrazepam dzia\u0142a na o\u015Brodki limbiczne i podwzg\u00F3rze. Zwi\u0119ksza powinowactwo kwasu gamma-aminomas\u0142owego do receptora GABA-A. Wykazuje przede wszystkim komponent\u0119 nasenn\u0105."@pl ,
		"Nitrazepam, C15H11N3O3, \u00E4r ett \u00E5ngestd\u00E4mpande och lugnande preparat som tillh\u00F6r gruppen bensodiazepiner. Varunamn i Sverige f\u00F6r \u00E4mnet \u00E4r Apodorm, Mogadon och Nitrazepam Recip. Nitrazepam anv\u00E4nds som s\u00F6mnmedel vid olika former av s\u00F6mnst\u00F6rningar, som till exempel sv\u00E5righeter att somna in, f\u00F6r tidigt uppvaknande och f\u00F6r m\u00E5nga nattliga uppvaknande. Nitrazepam anv\u00E4nds \u00E4ven vid behandling av vissa former av epilepsi, som fr\u00E4mst drabbar barn (infantil spasm och petit mal)."@sv ,
		"Nitrazepam is a type of benzodiazepine drug and is marketed in English-speaking countries under the following brand names - Alodorm, Arem, Insoma, Mogadon, Nitrados, Nitrazadon, Ormodon, Paxadorm, Remnos and Somnite. It is a hypnotic drug with sedative and motor impairing properties, anxiolytic, amnestic, anticonvulsant and skeletal muscle relaxant properties. Nitrazepam is available in 5mg and 10mg tablets. In Australia, Israel and the United Kingdom it is only available in 5mg tablets."@en ,
		"La Nitraz\u00E9pam est une substance chimique de la famille des benzodiaz\u00E9pines notamment commercialis\u00E9e sous le nom de Mogadon \u00AE, ainsi que sous forme de m\u00E9dicament g\u00E9n\u00E9rique. (D'autres sp\u00E9cialit\u00E9s en contenant existent, comme Imeson\u00AE). Comme toutes les mol\u00E9cules de sa famille, elle poss\u00E8de des propri\u00E9t\u00E9s anxiolytiques, hypnotiques ou s\u00E9datives, anticonvulsantes, et myorelaxantes, mais elle est surtout utilis\u00E9e comme hypnotique."@fr ;
	foaf:depiction	<http://upload.wikimedia.org/wikipedia/commons/6/6e/Nitrazepam.svg> .
@prefix skos:	<http://www.w3.org/2004/02/skos/core#> .
@prefix ns10:	<http://dbpedia.org/resource/Category:> .
dbpedia:Nitrazepam	skos:subject	ns10:Benzodiazepines ,
		ns10:Anticonvulsants ,
		ns10:Anxiolytics ,
		ns10:Muscle_relaxants ,
		ns10:Hypnotics ,
		ns10:Sedatives .
@prefix ns11:	<http://dbpedia.org/resource/Template:> .
dbpedia:Nitrazepam	dbpprop:wikiPageUsesTemplate	ns11:drugbox ;
	dbpprop:c	15 ;
	dbpprop:h	11 ;
	dbpprop:n	3 ;
	dbpprop:o	3 ;
	dbpprop:iupacName	"9-nitro- 6-phenyl- 2,5-diazabicyclo [5.4.0] undeca- 5,8,10,12- tetraen- 3-one"@en ;
	dbpprop:width	150 ;
	dbpprop:atcPrefix	"N05"@en .
@prefix xsd:	<http://www.w3.org/2001/XMLSchema#> .
dbpedia:Nitrazepam	dbpprop:casNumber	"0146-22-05"^^xsd:date ;
	dbpprop:image	"Nitrazepam-from-xtal-3D-balls.png"@en ;
	dbpprop:atcSuffix	"CD02"@en ;
	dbpprop:metabolism	dbpedia:Liver ;
	dbpprop:excretion	dbpedia:Kidney ;
	dbpprop:pubchem	4506 ;
	dbpprop:molecularWeight	"281.3 g/mol"@en ;
	dbpprop:chemspiderid	4350 ;
	dbpprop:eliminationHalfLife	"16-38 hours"@en ;
	dbpprop:legalStatus	" Schedule IV (International)"@en ;
	dbpprop:pregnancyUs	"D"@en ;
	dbpprop:pregnancyAu	"D"@en ;
	dbpprop:drugbank	"none"@en ;
	dbpprop:routesOfAdministration	"Oral"@en ;
	dbpprop:bioavailability	"53-94%"@en .
@prefix ns13:	<http://www4.wiwiss.fu-berlin.de/flickrwrappr/photos/> .
dbpedia:Nitrazepam	dbpprop:hasPhotoCollection	ns13:Nitrazepam .
dbpedia:Alodorm	dbpprop:redirect	dbpedia:Nitrazepam .
dbpedia:Mogadon	dbpprop:redirect	dbpedia:Nitrazepam .
dbpedia:C15H11N3O3	dbpprop:redirect	dbpedia:Nitrazepam .
dbpedia:Mogodon	dbpprop:redirect	dbpedia:Nitrazepam .